The Proposed Michigan Business Corporation Act

The author of this article was selected by the Commission as Reporter, to draft and revise the statute. It is the purpose of this article to describe the drafting process, to outline the general structure and to examine some unique aspects of the proposed Michigan Business Corporation Act. In this discussion, the author expresses his own views only, and does not necessarily reflect the opinions of the Law Revision Commission or its members

Liberalizing Michigan\u27s Corporate Law

Prof. Siegel served as Reporter to the Michigan Law Revision Commission to draft the proposed Michigan Business Corporation Law. His remarks reflect his own views, and not necessarily those of the Law Revision Commission. In the argot of the corporate lawyer, the term liberal takes on a special meaning when used to describe a body of laws governing corporations. A Iiberal corporation code contains the minimum number of limitations on corporate activity and has few, if any, sanctions to support its prohibitions. In the early days of this century, New Jersey, and later Delaware, earned the title Mother of Corporations by easing the strictures on corporations established under their laws. The fact that corporations even then operated beyond the boundaries of their chartering jurisdictions led to an influx of corporations that leaves its clear mark on American corporation law to this day. Of Fortune\u27s Top 500 Industrial Corporations, more than 200 are incorporated in Delaware, some 60 in New York, and more than 40 in New Jersey

Frey, Morris, Jr. & Choper: Cases and Materials on Corporations

A Review of Cases and Materials on Corporations By Alexander H. Frey, C. Robert Morris, Jr., and Jesse H. Chope

An Alternative to Politics in the Mails

Adapted from an address before the Economics Society of Michigan on March 29, 1969. In 1967, the American public contributed nearly $6 per capita to the deficit of the United States Post Office, a total of almost 91.2 billion. In 1968, after massive rate increases, the deficit will still approach 3600 million. Despite the rising cost of service, its quality has declined. For example, as many of us are painfully aware, where once the American household received mail deliveries twice daily, the single delivery of today doesn\u27t assure even overnight transmission of nearly one-third of first class mail. This combination of increasing cost and declining service bears striking contrast to the improved efficiency of both private enterprise and other government operations. What is wrong with the postal system? The answer, at least for the government overseers of the postal system, is uncomfortable: the mechanisms of government control are totally unsuited to the running of a business enterprise

Alfred Conard

A tribute to Alfred Conar

The United States Post Office, Incorporated: A Blueprint for Reform

For several generations, the United States Post Office has been the textbook demonstration of the inefficiency of the government in business. To some, the solution to its problems lies only in turning over its functions to free enterprise. A more constructive and politic approach is to inquire whether a structural arrangement falling somewhere between that of a governmental department and that of a privately owned business would permit the Post Office to achieve some of the efficiencies of private enterprise without compromising the most essential elements of public responsibility. This approach has been given new timeliness by the proposal of Postmaster General O\u27Brien to convert the Post Office into a public corporation

Clinical perspectives of emerging pathogens in bleeding disorders.

As a result of immunological and nucleic-acid screening of plasma donations for transfusion-transmissible viruses, and the incorporation of viral reduction processes during plasma fractionation, coagulation-factor concentrates (CFC) are now judged safe in terms of many known infectious agents, including hepatitis B and C viruses, HIV, and human T-cell lymphotropic virus. However, emerging pathogens could pose future threats, particularly those with blood-borne stages that are resistant to viral-inactivation steps in the manufacturing process, such as non-lipid-coated viruses. As outlined in this Review, better understanding of infectious diseases allows challenges from newly described agents of potential concern in the future to be anticipated, but the processes of zoonotic transmission and genetic selection or modification ensure that plasma-derived products will continue to be subject to infectious concerns. Manufacturers of plasma-derived CFC have addressed the issue of emerging infectious agents by developing recombinant products that limit the need for human plasma during production. Such recombinant products have extended the safety profile of their predecessors by ensuring that all reagents used for cell culture, purification steps, and stabilisation and storage buffers are completely independent of human plasma